Search results

  1. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 25 June 2021

  2. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  3. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  4. Antenatal care

    In development [GID-NG10096] Expected publication date: 11 August 2021

  5. Inducing labour (update)

    In development [GID-NG10082] Expected publication date: 14 October 2021

  6. Weight Management

    In development [GID-NG10182] Expected publication date: 22 June 2023

  7. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 01 November 2023

  8. Eculizumab for treating atypical haemolytic uraemic syndrome (HST1)

    Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children

  9. Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (HST3)

    Evidence-based recommendations on ataluren (Translarna) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene in people aged

  10. Inotersen for treating hereditary transthyretin amyloidosis (HST9)

    Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

  11. Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

    Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children